课题基金 / 基金详情

项目摘要

项目成果

ROBERT W BUCHANAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们的ACISIR的使命:促进精神分裂症患者的康复,是推进精神分裂症患者的治疗,以减少痛苦和改善功能结果,最终目标是促进康复之路。马里兰州精神病学研究中心的基础临床研究专业知识将与服务研究司和精神分裂症行为治疗中心的服务和干预专业知识相结合,以告知社区环境中循证实践的发展,评估和实施。循证实践的发展将侧重于以下领域:1)难治性阳性症状; 2)持续性阴性症状; 3)认知障碍; 4)同时发生的药物滥用; 5)同时发生的医疗状况; 6)促进康复。对社区实践的评估和循证实践的实施将侧重于以下领域:1)药物治疗实践; 2)健康和保健干预; 3)社区保有权和职业提升计划;以及d)以消费者和家庭为中心的干预。ACISIR将通过以下方式支持这项工作:1)为研究者提供评估、数据管理、统计和受试者招募基础设施支持; 2)通过拟议的核心服务实践-实践研究网络开发和维护对各种临床站点的访问; 3)开发和维护反映马里兰州一般实践的数据库,并能够交叉引用不同数据集的结果; 4)促进多学科研究和规划,以开发创新的新技术、方法和设计,从而发展和实施循证实践; 5)开发创新的伦理方法; 6)确保社区利益相关者在我们研究的各个方面做出贡献;以及7)为临床研究的学员提供培训。 运营核心
英文摘要
DESCRIPTION (provided by applicant): The mission of our ACISIR: Enhancing Recovery of People with Schizophrenia, is to advance the treatment of people with schizophrenia in order to reduce suffering and to improve functional outcomes, with the ultimate goal of promoting the path to recovery. The basic clinical research expertise of the Maryland Psychiatric Research Center will be integrated with the services and intervention expertise of the Division of Services Research and the Center for Behavioral Treatment of Schizophrenia to inform the development, evaluation and implementation of evidence-based practices in community settings. The development of evidence-based practices will focus on the following areas: 1) treatment-resistant positive symptoms; 2) persistent negative symptoms; 3) cognitive impairments; 4) co-occurring substance abuse; 5) co-occurring medical conditions; and 6) enhancing recovery. The evaluation of community-based practices and implementation of evidence-based practices will focus on the following areas: 1) pharmacological treatment practices; 2) health and wellness interventions; 3) community tenure and occupational enhancement programs; and d) consumer and family centered interventions. The ACISIR will support this work by: 1) providing assessment, data management, statistical, and subject recruitment infrastructure support for investigators; 2) developing and maintaining access to a variety of clinical sites through the proposed Core Service Agency-Practice Research Network; 3) developing and maintaining databases reflecting general practice in Maryland, with the ability to cross-reference findings across different datasets; 4) fostering multi- disciplinary research and planning in order to develop innovative new technologies, methods, and designs for the development and implementation of evidence-based practices; 5) developing innovative ethics methods; 6) ensuring the contribution of community stakeholders in all aspects of our research; and 7) providing training for trainees in clinical research. Operations Core
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prebiotic Treatment in People with Schizophrenia
  • 批准号:
    10677261
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2022
  • 负责人:
    ROBERT W BUCHANAN
  • 依托单位:
Prebiotic Treatment in People with Schizophrenia
  • 批准号:
    10704720
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2022
  • 负责人:
    ROBERT W BUCHANAN
  • 依托单位:
Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum Disorders
Prebiotic Treatment in People with Schizophrenia
  • 批准号:
    10448075
  • 项目类别:
  • 资助金额:
    $16.75万
  • 财政年份:
    2018
  • 负责人:
    ROBERT W BUCHANAN
  • 依托单位:
海外基金